GFAP and Alzheimer disease: An AD-related study from the Translational Biomarkers in Aging and Dementia (TRIAD) cohort reported that CSF GFAP levels were notably elevated in both the A + T − and A + T + groups when compared to the A–T − group, although no statistical differences were discerned between the A + T − and A + T + groups [44].